Sbi Securities Co., Ltd. Zai Lab LTD Transaction History
Sbi Securities Co., Ltd.
- $3.9 Trillion
- Q3 2025
A detailed history of Sbi Securities Co., Ltd. transactions in Zai Lab LTD stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 21 shares of ZLAB stock, worth $456. This represents 0.0% of its overall portfolio holdings.
Number of Shares
21
Previous 50
58.0%
Holding current value
$456
Previous $1.75 Million
59.29%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ZLAB
# of Institutions
152Shares Held
32.7MCall Options Held
168KPut Options Held
222K-
Capital World Investors Los Angeles, CA6.08MShares$132 Million0.03% of portfolio
-
Clearbridge Investments, LLC New York, NY3.52MShares$76.5 Million0.09% of portfolio
-
Rtw Investments, LP New York, NY2.29MShares$49.8 Million1.04% of portfolio
-
Janus Henderson Group PLC London, X02.05MShares$44.6 Million0.03% of portfolio
-
Wellington Management Group LLP Boston, MA1.72MShares$37.4 Million0.01% of portfolio
About Zai Lab Ltd
- Ticker ZLAB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 97,908,704
- Market Cap $2.13B
- Description
- Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...